Taken together, our data show the multifaceted dysregulation of the NF-κB pathway in mesothelioma, shedding light on activation mechanisms and downstream inflammatory signatures, with potential implications for understanding and targeting the inflammatory milieu in this malignancy. This evidence concerns the gene NFKB1 and mesothelioma.